RUNX3 Improves CAR-T Cell Phenotype and Reduces Cytokine Release While Maintaining CAR-T Function

CAR-T cells overexpressing RUNX3 were safer than conventional CAR-T cells, while RUNX3 could also maintain the anti-tumor efficacy of CAR-T cells in vivo.